Notice NOT-AG-21-047 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-048 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-049 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-050 from the NIH Guide for Grants and Contracts

Notice NOT-HG-22-011 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-045 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-046 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-044 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-041 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-042 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-23-006 from the NIH Guide for Grants and Contracts. The National Institute on Aging seeks applications for the Coordinating Center (CC) of the Claude D. Pepper Older Americans Independence Centers (OAIC) program. The CC serves as a facilitator for OAIC site interactions and as a conduit for translating OAIC objectives and findings to both scientific and general audiences. The proposed CC must demonstrate an ability to work cooperatively with all OAIC sites and possess sufficient scientific expertise in geriatrics and related areas to serve the national coordination functions of the OAIC program. The CC should be proposed only by institutions with (1) the ability to coordinate multi-site projects as demonstrated by previous HHS funding for a coordinating center of a multi-site research grant, and (2) demonstrated scientific expertise in clinical aging research.

Notice NOT-DA-22-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-057 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from early and mid-career investigators (i.e. postdoctoral fellow/associates associate professor) who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of therapeutic drug, biologic, or device development. The development of novel treatments for pain, addiction, and overdose is a vital component to address the ongoing opioid epidemic. This development will be most effective if performed by scientists with training in translational science. Translation is defined as the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public from diagnostics and therapeutics to medical procedures and behavioral changes, with translational science representing the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process (https://ncats.nih.gov/translation). Traditional academic training provides deep knowledge of a relatively narrow scientific discipline. While domain expertise is an important characteristic of a proficient translational scientist, a comprehensive understanding of the stages of therapeutic development is also necessary. For many trainees, acquiring needed expertise through participatory training in the various fields that are required to compile an investigational new drug (IND), investigational device exemption (IDE), or new drug application (NDA) is extraordinarily difficult given the diversity of these domains.

£37,865-£45,359 per annum + benefits: Wellcome Sanger Institute: We are seeking a highly motivated senior bioinformatician with experience in handling large genomic sequencing datasets to join the Martin group an... Cambridgeshire

Funding Opportunity RFA-MD-22-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a technology or product, process, or service for commercialization to improve, reduce, and eliminate health disparities in one or more NIH-defined population groups. Appropriate technologies should be effective, affordable, and culturally acceptable.

Funding Opportunity RFA-MD-22-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations experiencing health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.

Funding Opportunity RFA-HL-23-003 from the NIH Guide for Grants and Contracts. The purpose of this limited competition R00 program is to provide physician scientists in blood science with a seamless pathway from a mentored K99/R00 award to investigator independence. Eligible applicants will have matriculated through the Career Pathway to Independence in Blood Science Awards for Physician Scientists ( K99/R00) program for up to three, but no more than five years. The strongest R00 applicants will propose an updated, well-conceived plan for 23 years of independent research support intended to prepare the applicant to subsequently compete for an R01 or equivalent award. These research projects are limited to those that fall within the Division of Blood Diseases and Resources mission. The NIH encourages institutions to recruit and retain individuals from groups currently underrepresented in the biomedical sciences, and to enhance the diversity of the clinician-investigator workforce (NOT-OD-15-053).

Funding Opportunity RFA-AG-23-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for pharmacokinetic and pharmacodynamic (PK/PD) studies of mTOR inhibitors inpopulations living with different aging-related diseases or in relatively healthy older adult populations at risk for a variety of aging conditions. The studies will be funded by individual awards but will be required to interact as a network to exchange information, possibly develop harmonized measures, and pool data to facilitate broader assessment of the effects on multiple aging-related outcomes and mechanisms affected by mTOR modulation.

Notice NOT-OD-22-051 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-363 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from qualified institutions to develop or renovate breeding and research space for basic, translational, clinical, and social/behavioral science research using non-human primates (NHPs). This FOA targets NHP facilities supported by NIH. Any request must be justified by current and anticipated future research needs.